CDKN2A and myocardial infarction: Both CDKN2A and ‐B are expressed in human carotid plaques, and one study reported lower levels of CDKN2B in the peripheral blood of MI patients and carriers of a 9p21.3 risk allele (Holdt et al., 2011; Zivotić et al., 2019).